#152793

Anti-DRAM2 [VAB24-P1C8*A3]

Cat. #152793

Anti-DRAM2 [VAB24-P1C8*A3]

Cat. #: 152793

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 10-12 weeks

Target: DNA-Damage Regulated Autophagy Modulator 2 (DRAM2)

Class: Monoclonal

Application: ELISA ; IHC ; WB

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Ayham Alnabulsi

Institute: Vertebrate Antibodies Limited

Tool Details
Target Details
Applications
Handling

Tool Details

*FOR RESEARCH USE ONLY

  • Name: Anti-DRAM2 [VAB24-P1C8*A3]
  • Alternate name: 2135N14Rik, 261318G18Rik, AI647667, damage regulated autophagy modulator 2, DNA damage regulated autophagy modulator 2, DNA damage regulated autophagy modulator protein 2, DNA damage-regulated autophagy modulator protein 2, Dram2, DRAM2_HUMAN, PRO18, PSEC31, RP5-118E21.1, Tmem77, Transmembrane protein 77, WWFQ154
  • Clone: VAB24-P1C8*A3
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Strain: Balb/c
  • Reactivity: Human
  • Host: Mouse
  • Application: ELISA ; IHC ; WB
  • Description: DRAM2's expression is down-regulated in ovarian tumors (at protein level). Widely expressed with highest levels in placenta and heart. Not detected in brain or thymus.
  • Immunogen: Ovalbumin-conjugated synthetic peptide HGLTLYDTAP. Note that peptide immunogen is identical in sheep (Ovis aries), cow (Bos taurus), dog (Canis familiaris), pig (Sus scrofa) and horse (Equus caballus).
  • Isotype: IgG1 kappa
  • Myeloma used: P3X63Ag8.653
  • Recommended controls: IHC - formalin-fixed, paraffin-embedded multi tumour tissue microarray

Target Details

  • Target: DNA-Damage Regulated Autophagy Modulator 2 (DRAM2)
  • Tissue cell line specificity: IHC - formalin-fixed, paraffin-embedded multi tumour tissue microarray
  • Target background: DRAM2's expression is down-regulated in ovarian tumors (at protein level). Widely expressed with highest levels in placenta and heart. Not detected in brain or thymus.

Applications

  • Application: ELISA ; IHC ; WB

Handling

  • Format: Liquid
  • Concentration: 0.9-1.1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -15° C to -25° C
  • Shipping conditions: Shipping at 4° C